Literature DB >> 34400778

The prefrontal cortex and OCD.

Susanne E Ahmari1,2,3, Scott L Rauch4,5.   

Abstract

Obsessive Compulsive Disorder (OCD) is a highly prevalent and severe neuropsychiatric disorder, with an incidence of 1.5-3% worldwide. However, despite the clear public health burden of OCD and relatively well-defined symptom criteria, effective treatments are still limited, spotlighting the need for investigation of the neural substrates of the disorder. Human neuroimaging studies have consistently highlighted abnormal activity patterns in prefrontal cortex (PFC) regions and connected circuits in OCD during both symptom provocation and performance of neurocognitive tasks. Because of recent technical advances, these findings can now be leveraged to develop novel targeted interventions. Here we will highlight current theories regarding the role of the prefrontal cortex in the generation of OCD symptoms, discuss ways in which this knowledge can be used to improve treatments for this often disabling illness, and lay out challenges in the field for future study.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Year:  2021        PMID: 34400778      PMCID: PMC8617188          DOI: 10.1038/s41386-021-01130-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  204 in total

1.  Association of Obsessive-Compulsive Disorder With Objective Indicators of Educational Attainment: A Nationwide Register-Based Sibling Control Study.

Authors:  Ana Pérez-Vigil; Lorena Fernández de la Cruz; Gustaf Brander; Kayoko Isomura; Andreas Jangmo; Inna Feldman; Eva Hesselmark; Eva Serlachius; Luisa Lázaro; Christian Rück; Ralf Kuja-Halkola; Brian M D'Onofrio; Henrik Larsson; David Mataix-Cols
Journal:  JAMA Psychiatry       Date:  2018-01-01       Impact factor: 21.596

2.  Searching for an anchor in an unpredictable world: A computational model of obsessive compulsive disorder.

Authors:  Isaac Fradkin; Rick A Adams; Thomas Parr; Jonathan P Roiser; Jonathan D Huppert
Journal:  Psychol Rev       Date:  2020-02-27       Impact factor: 8.934

Review 3.  Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V.

Authors:  James F Leckman; Damiaan Denys; H Blair Simpson; David Mataix-Cols; Eric Hollander; Sanjaya Saxena; Euripedes C Miguel; Scott L Rauch; Wayne K Goodman; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 4.  The two-step task, avoidance, and OCD.

Authors:  Matthew A Geramita; Eric A Yttri; Susanne E Ahmari
Journal:  J Neurosci Res       Date:  2020-04-13       Impact factor: 4.164

5.  Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS).

Authors:  Christine Lochner; Naomi A Fineberg; Joseph Zohar; Michael van Ameringen; Alzbeta Juven-Wetzler; Alfredo Carlo Altamura; Natalie L Cuzen; Eric Hollander; Damiaan Denys; Humberto Nicolini; Bernardo Dell'Osso; Stefano Pallanti; Dan J Stein
Journal:  Compr Psychiatry       Date:  2014-06-09       Impact factor: 3.735

6.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.

Authors:  L R Baxter; M E Phelps; J C Mazziotta; B H Guze; J M Schwartz; C E Selin
Journal:  Arch Gen Psychiatry       Date:  1987-03

7.  Mortality Among Persons With Obsessive-Compulsive Disorder in Denmark.

Authors:  Sandra M Meier; Manuel Mattheisen; Ole Mors; Diana E Schendel; Preben B Mortensen; Kerstin J Plessen
Journal:  JAMA Psychiatry       Date:  2016-03       Impact factor: 21.596

8.  Using Optogenetics to Dissect the Neural Circuits Underlying OCD and Related Disorders.

Authors:  Sean C Piantadosi; Susanne E Ahmari
Journal:  Curr Treat Options Psychiatry       Date:  2015-07-15

Review 9.  Goal-directed learning and obsessive-compulsive disorder.

Authors:  Claire M Gillan; Trevor W Robbins
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-11-05       Impact factor: 6.237

Review 10.  The role of habit in compulsivity.

Authors:  Claire M Gillan; Trevor W Robbins; Barbara J Sahakian; Odile A van den Heuvel; Guido van Wingen
Journal:  Eur Neuropsychopharmacol       Date:  2015-12-29       Impact factor: 4.600

View more
  5 in total

1.  Gray Matter Alterations in Pediatric Schizophrenia and Obsessive-Compulsive Disorder: A Systematic Review and Meta-Analysis of Voxel-Based Morphometry Studies.

Authors:  Jingran Liu; Fang Wen; Junjuan Yan; Liping Yu; Fang Wang; Duo Wang; Jishui Zhang; Chunmei Yan; Jiahui Chu; Yanlin Li; Ying Li; Yonghua Cui
Journal:  Front Psychiatry       Date:  2022-03-02       Impact factor: 4.157

2.  BDNF Alleviates Microglial Inhibition and Stereotypic Behaviors in a Mouse Model of Obsessive-Compulsive Disorder.

Authors:  Yuchong Luo; Xiao Chen; Chunren Wei; Hongyang Zhang; Lingyi Zhang; Lu Han; Ke Sun; Boxing Li; Shenglin Wen
Journal:  Front Mol Neurosci       Date:  2022-07-12       Impact factor: 6.261

3.  Sustained attention induces altered effective connectivity of the ascending thalamo-cortical relay in obsessive-compulsive disorder.

Authors:  Mario A Yacou; Asadur Chowdury; Philip Easter; Gregory L Hanna; David R Rosenberg; Vaibhav A Diwadkar
Journal:  Front Psychiatry       Date:  2022-08-10       Impact factor: 5.435

4.  Cytoarchitecture, intersubject variability, and 3D mapping of four new areas of the human anterior prefrontal cortex.

Authors:  Ariane Bruno; Sebastian Bludau; Hartmut Mohlberg; Katrin Amunts
Journal:  Front Neuroanat       Date:  2022-08-11       Impact factor: 3.543

5.  Subjective assessments of research domain criteria constructs in addiction and compulsive disorders: a scoping review protocol.

Authors:  Ana Paula Ribeiro; Marcelo Piquet-Pessôa; Carina Félix-da-Silva; Julia Fernandes Eigenheer Mühlbauer; Juliana B de-Salles-Andrade; Leonardo F Fontenelle
Journal:  BMJ Open       Date:  2022-08-26       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.